This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Christopher Seet: Innovator in T-Cell Generation
Introduction
Christopher Seet is a prominent inventor based in Santa Monica, CA. He has made significant contributions to the field of immunotherapy, particularly in the generation of T-cells from stem cells. His innovative work has the potential to advance therapeutic methods for various diseases.
Latest Patents
Christopher Seet holds a patent for "Methods or generating T-cells from stem cells and immunotherapeutic methods using the T-cells." This patent outlines methods and compositions for the production of T cells. It also describes therapeutic methods utilizing engineered T cells. For instance, the methods include preparing three-dimensional cell culture compositions comprising stroma cells and hematopoietic stem or progenitor cells in a serum-free medium for producing T cells. He has 1 patent to his name.
Career Highlights
Christopher Seet is affiliated with the University of California, where he continues to push the boundaries of research in immunotherapy. His work is instrumental in developing new therapeutic strategies that leverage the power of T-cells.
Collaborations
He has collaborated with notable colleagues such as Gay M Crooks and Amélie Montel-Hagen, contributing to a rich environment of innovation and research.
Conclusion
Christopher Seet's contributions to the field of immunotherapy through his innovative methods for T-cell generation highlight his role as a key inventor in this vital area of research. His work promises to pave the way for new therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile